Do you want to read an article? Please log in or register.
Deep Learning Discriminates Thymic Epithelial Tumors Histological Subtypes Using Digital Pathology
Lung, Respiratory and Thoracic Cancer
Related content
Lung, Respiratory and Thoracic Cancer
Tumour dimension is a prognostic factor in thymic epithelial tumours: An update analysis from the ESTS thymic database: Tumour dimension in thymic tumours
Lung Cancer
Chiappetta M, Lococo F, Sassorossi C, Moser B, Schil PV, Podobed A, Liberman M, Opitz I, Zisis C, Menghesha H, Furak J, Mendogni P, Ruffini E, Guerrera F, Venuta F, Voltolini L, Londero F, Casiraghi M, Bravio I, Voulaz E, Barmin V, Trancho FH, Billè A, Cafarotti S, Campanella A, Santoro G, Novoa NM, Margaritora S, ESTS Working Group, ESTS Thymic Database Participants
doi: 10.1016/j.lungcan.2025.108535
Lung, Respiratory and Thoracic Cancer
Diagnostic and prognostic relevance of inflammatory markers in surgically treated thymic epithelial tumors: An international multicenter study
Lung Cancer
Megyesfalvi E, Ghimessy A, Bauer J, Pipek O, Saghi K, Gellert A, Fillinger J, Okumus O, Teglas V, Ganofszky E, Bogos K, Renyi-Vamos F, Megyesfalvi Z, Aigner C, Hegedus B, Dome B, Moser B
doi: 10.1016/j.lungcan.2025.108111
Genitourinary CancerRadio-Oncology
Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN0533
J Clin Oncol
Dix DB, Khanna G, Renfro LA, Tfirn IC, Smith EA, Artunduaga M, Eklund MJ, Sandberg JK, Parsons LN, Kalapurakal JA, Ehrlich PF, Aldrink JH, Glick RD, Benedetti DJ, Fernandez CV, Dome JS, Mullen EA, Geller JI, COG Renal Tumor Committee
doi: 10.1200/JCO-25-00532
Further Publications
Circulating tumor DNA Clearance as a Predictive Biomarker of Pathologic Complete Response in Patients with Solid Tumors Treated with Neoadjuvant Immune-Checkpoint Inhibitors: a Systematic Review and Meta-Analysis
Ann Oncol
Valenza C, Saldanha EF, Gong Y, De Placido P, Gritsch D, Ortiz H, Trapani D, Conforti F, Cremolini C, Peters S, Mateo J, Subbiah V, Parsons HA, Partridge AH, Curigliano G
doi: 10.1016/j.annonc.2025.03.019
Lung, Respiratory and Thoracic Cancer
Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME database
Lung Cancer
Leuzzi G, Sabia F, Proto C, Lo Russo G, Ganzinelli M, Ferrari M, Perrino M, Cordua N, Checchi L, De Vincenzo F, Federico A, Zucali P, Lucchi M, Ambrogi MC, Aprile V, Mendogni P, Rosso L, Cecere FL, Comacchio G, Bianco R, Paolo Di Pietro M, Fabbri A, Petrini I, Trama A, De Pas TM, Conforti F, Galli G, Ruffini E, Garassino MC, Franceschini D, Berardi R, Pasello G, Solli P, TYME GROUP
doi: 10.1016/j.lungcan.2025.108871
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approach
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Rosenlund L, Guldbrandsen K, Ahlborn LB, Bloch M, Skougaard K, Albrecht-Beste E, Nellemann HM, Krakauer M, Gørtz PM, Fledelius J, Nielsen AL, Holdgaard PC, Nielsen SS, Grüner JM, Højsgaard A, Petersen RH, Møller LB, Dahl M, Frank MS, Ehlers JH, Saghir Z, Pøhl M, Borissova S, Land LH, Kristiansen C, McCulloch T, Mortensen LS, Christophersen MS, Hilberg O, Rasmussen TL, Simonsen Schwaner SH, Laursen CB, Bodtger U, Lonsdale MN, Meyer CN, Gerke O, Mortensen J, Rasmussen TR, Hjorthaug K, Larsen KR, Meldgaard P, Fischer BM, Sorensen BS
doi: 10.1016/j.lungcan.2025.108528
Skin Cancer
Pathological response calculation assessment remains accurate with reduced tumor bed examination following neoadjuvant immunotherapy in clinically detectable stage III melanoma
Ann Oncol
Rawson RV, Maher NG, Menzies AM, Lo SN, Ardakani NM, Jackett LA, Vergara IA, Pennington TE, Shannon KF, Ch'ng S, Gonzalez M, Burton EM, Lucas MW, Reijers ILM, Rozeman EA, Gyorki DE, Sandhu S, Carlino MS, Howle J, Khattak M, Van der Westhuizen A, Andrews MC, Atkinson V, van Akkooi ACJ, Spillane AJ, Saw RPM, van de Wiel BA, Blank CU, Long GV, Tetzlaff MT, Scolyer RA
doi: 10.1016/j.annonc.2025.10.1237
Genitourinary Cancer
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials
J Clin Oncol
Armstrong AJ, Liu VYT, Selvaraju RR, Chen E, Simko JP, DeVries S, Sartor O, Sandler HM, Mohamad O, Huang HC, Griffin J, Yamashita R, Esteva A, Tran PT, Spratt DE, Carson JH, Peters C, Gore E, Lee SP, Monson JM, Augspurger ME, El-Gayed A, Rodgers JP, McKay R, Morgan T, Feng FY, Nguyen PL
doi: 10.1200/JCO.24.00365
Lung, Respiratory and Thoracic Cancer
Therapeutic modalities for superior sulcus tumor (Pancoast) tumor - A systematic review
Lung Cancer
Langer S, Medenwald D, Vordermark D, Schuette W, Deppermann KM, Nothacker M, Eggeling S, Efremov L
doi: 10.1016/j.lungcan.2025.108640